Medical Research

Technion vs Superbug: Technion Prof. Roy Kishony is developing research to reverse the development of antibiotic resistance.

If you suffer from cancer or Parkinson’s disease, it’s possible that at least part of your treatment was developed at the Technion. Velcade, for the treatment of multiple myeloma, grew out of Nobel Prize winning research of Technion Professors Aaron Ciechanover and Avram Hershko. Azilect, for the treatment of Parkinson’s, was developed by Professor Emeritus Dr. Moussa Youdim, who is now helping to create the first-ever blood test for early diagnosis of the disease. And many promising research projects are underway for the treatment of heart disease.

The combination of engineering and medicine at the Lorry I. Lokey Interdisciplinary Center for Life Sciences and Engineering has helped lay the foundation for a thriving medical device industry in Israel that has improved the quality of life for people all over the world. ReWalk and UPnRIDE (mobility devices for paraplegics and quadriplegics), Pillcam (capsule endoscopy) and the miniature surgical robots of Mazor Robotics and Microbot Medical were developed by Technion professors and alumni, as were the non-invasive tumor ablation systems of InSightec and the electric tumor treating fields of Novocure.

Technion Breakthroughs in Medical Research

Click here to read the Technion Medical Review

Click below to watch more videos about Technion innovations in medical research:

Technion biophysicist Professor Kinneret Keren’s findings on how hydra regrow lost body parts might one day be useful for human tissue regeneration.

Professor Meytal Landau’s new approach to fighting the superbug could lead to new types of antibiotics.

Users demonstrate Technion alumnus Dr. Amit Goffer’s UPnRIDE and ReWalk, mobility devices for quadriplegics and paraplegics.

Professor Moshe Shoham, Co-Founder of Mazor Robotics and Microbot Medical and head of the Technion’s Kahn Medical Robotics Laboratory, discusses the renaissance in robotic spine and brain surgery.

For more information about Technion medical research, email breakthroughs@ats.org or follow #TechnionBreakthrough across social media.